Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Panax and Radix Polygoni Capsule is a combination product developed by Tongli Pharmaceuticals, consisting of extracts from Panax ginseng and Radix Polygoni. This traditional Chinese medicine is formulated as a capsule for oral administration. The active components in Panax ginseng, known as ginsenosides, are believed to function as adaptogens, helping the body manage stress, and have demonstrated a range of effects including anti-inflammatory, antioxidant, and immunomodulatory properties. Radix Polygoni, likely from *Polygonum multiflorum* (He Shou Wu), is traditionally used to nourish the liver and kidney and has been studied for its antioxidant and lipid-regulating effects. The combination was commercialized and distributed in several cities in China under an agreement between Tongli Pharmaceuticals and Shandong Shanglian Biochemical Medicine Limited Company.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on panax + radix polygoni.